AstraZeneca Bristol-Myers-Squibb Satellite Symposium - The 2nd Latin America Congress on Controversies to Consensus to Diabetes, Obesity and Hypertension (CODHy)

The 2nd Latin America Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Rio de Janeiro, Brazil, March 22-25, 2012

AstraZeneca Bristol-Myers-Squibb Satellite Symposium

This educational programme is accredited by the Royal College of Physicians of the United Kingdom for 2 credits

Friday, March 23, 2012
17:00-19:00

SGLT2 inhibition and the ‘CODHy’ controversies: glycaemic control and beyond

17:00-17:30

Light refreshments

17:30-17:45

Welcome and introduction
Antonio R. Chacra, Chair
São Paulo, Brazil

17:45-18:10

The challenges of managing vascular risk in T2DM
A. Enrique Caballero
Boston, USA

18:10-18:35

SGLT2 inhibitors: a new approach to treatment in T2DM?
Artur B. Ribeiro
São Paulo, Brazil

18:35-19:00

SGLT2 inhibitors: clinical experience
John Wilding
Liverpool, UK